2020 New Drug Approvals: Review of New FDA and EMA Marketing Authorisations

Posted by Andre Moa on Nov 17, 2020 11:21:59 AM


Any fears that COVID-19 might stem the flow of new drug approvals in 2020, depleting or diverting resources at regulatory agencies and their pharmaceutical clients, appear largely premature.

Read More

Topics: Pharma launch planning, launch readiness, EMA Approvals, FDA Approvals